The study, published in the journal Anesthesiology, found that in a group of 1,005 vascular surgery patients, symptomatic and asymptomatic LV dysfunction was associated with cardiovascular events, including myocardial infarction, and cardiovascular-related death 30 days following surgery.
Researchers recommended evaluation for all possible cardiovascular risk factors in high risk surgery patients and recommended perioperative therapy such as beta-blockers to improve outcomes.
Read the ASA’s release about cardiovascular risk in surgery.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
